The company aims to seek US and European approval later this year.
The investment bank maintained its stock ratings for Hologic, Cepheid, and T2 Biosystems.
The self-contained, cartridge-based test runs on the firm's GeneXpert system.
The company is using a $3 million, three-year grant to clinically validate the test, which it hopes will be the first of its kind approved by the FDA.
Sensitivity of GeneXpert MTB/RIF was better than microscopy, but low enough compared to culture to conclude that a negative Xpert result does not rule out TB in children.
In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.
GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.
Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.
A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.